Summary of Purpose
To investigate the efficacy of an ACE inhibitor (ramipril) and vitamin E in improving the long-term outcome of patients at high risk for cardiovascular events.Read More →
The following dates are available for this trial. Trial information last updated on 1 December 2009.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Canadian Institutes for Health Research, Aventis, AstraZeneca, King Pharmaceuticals, Natural Source Vitamin E Association, Negma, Heart and Stroke Foundation of Ontario
Randomized, multicenter, double-blind, placebo-controlled, three-by-two factorial study